Don’t Jump to Topical Zoryve for Psoriasis
July 2023
Zoryve (roflumilast 0.3%) will be a new once-daily Rx cream for psoriasis.
It’s the first phosphodiesterase 4 (PDE4) inhibitor CREAM for patients age 12 and older with psoriasis.
Keep in mind that Daxas (roflumilast) TABS are for COPD...and Eucrisa (crisaborole) OINTMENT is also a PDE4 inhibitor, but it’s for eczema.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive